Thu, Apr 7, 2022 4:06 PM
USFDA gives nod to Alembic Pharma for Dabigatran Etexilate Capsules
A Flip by Flipitnews
Indegene IPO subscription status: On the second day of bidding, Indegene IPO maintains its pace and navigates through unfavourable market sentiment. The initial public offer of integrated solutions provider Indegene has received 5.09 times subscription on day 2, at 14:54 IST, as per BSE data.The quota for Qualified Institutional Buyers (QIBs) got subscribed 1.66 times.
Open Flip
Three years since a worldwide race to the cloud boosted India's IT services sector, there are signs of a re-run. Microsoft Azure, Amazon Web Services (AWS) and Google Cloud clocked record new business in the January-March period, a development which could help India's largest technology services firms grow faster in the current financial year than last, company executives and analysts said.
Open Flip
Fool.com contributor Parkev Tatevosian previews what investors should expect from Alibaba's (NYSE: BABA) earnings announcement.*Stock prices used were the afternoon prices of May 4, 2024. The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Alibaba Group wasn’t one of them.
Open Flip
